- Clinical summaries
- no comment
Vitamin D level and myocardial infarction: what is the link?
Meta-analysis evaluates the association of vitamin D levels with myocardial infarction.
Recommended in General Medicine
- Clinical summaries
- 1 comment
Prediabetes: is elevated uric acid a warning?
- Univadis Medical News
- 1 comment
Cancer Research UK offers €20 million in funding for international collaborations
- Univadis Medical News
- 1 comment
Oral hormone therapies tied to ischemic stroke risk
- Univadis Medical News
- 1 comment
Elders with poor quality sleep are prone to falls
- Clinical summaries
- 1 comment
Stroke: smoking biggest risk factor for men, hypertension for women
- Univadis Medical News
- 1 comment
Proton pump inhibitors do not increase risk for dementia
- The Lancet
- 1 comment
- FULLTEXT
Risk of Zika-related microcephaly varies across different regions in brazil
- Atherosclerosis
- no comment
- FULLTEXT
Fibroblast growth factor 23 and cardiovascular and all-cause mortality
Professional & Business
- International Medical Press
Heart disease deaths drop since smoking ban
- International Medical Press
Public dissatisfaction with NHS at record high
- International Medical Press
‘Downturn’ of HIV epidemic among men
- International Medical Press
Rising cost of NHS negligence claims ‘unsustainable’
- International Medical Press
BMA: government fails to acknowledge NHS ‘at breaking point’
- International Medical Press
Call for improved GP resources as postnatal depression missed
New in General Medicine
- The Lancet Neurology
- 1 comment
- FULLTEXT
Correlation between olfactory dysfunction and neurodegenerative diseases
Understanding whether neurodegenerative diseases cause olfactory dysfunction, or whether infections/pollution also contribute
- Clinical Essentials from Oncotarget
- 1 comment
Breast cancer prevention: long-term, frequent use of aspirin has protective effect
Results of a meta-analysis involving 857K participants.
- Clinical Essentials from Curr Infect Dis Rep
- 1 comment
Zika: characterization lacking in non-congenitally-acquired child infections
Lack of data on manifestations in non-congenitally-acquired Zika infections dictates clinician familiarity with what is already known.
- Clinical Essentials from J Prim Care Community Health
- 1 comment
Care management improves outcomes in obesity, diabetes
Reduced weight, HbA1c seen in primary care settings.
- Clinical Essentials from Diabetes Obes Metab
- 1 comment
Type 2 diabetes: fixed-dose DPP-4i plus metformin combo tops separate pills
Reducing pill burden may improve T2DM control.
- Clinical Essentials from J Am Med Dir Assoc
- 1 comment
Influenza and pneumococcal vaccination: nursing home residents falling short
Nursing home administrators can use standing orders and provider reminders to ensure compliance.
- Clinical Essentials from Sleep Breath
- 1 comment
Sleep apnea improved by head elevation
Head-of-bed elevation could be a simple alternative to existing OSA treatments.
- Clinical Essentials from Am J Hypertens
- 1 comment
Stroke outcomes associated with BP variability
Findings help clarify the controversial link between BPV and stroke outcomes.
- Clinical Essentials from Carcinogenesis
- 1 comment
Beauty at what cost? Hair product use linked to increased breast cancer risk
Dark hair dyes, relaxers in particular linked to increased risk.
- Clinical Essentials from J Am Heart Assoc
- 1 comment
Smoking linked to early CVD
Subclinical injury can be detected early in the disease process.
- Monthly Essentials
- 1 comment
Diabetes: Monthly Essentials June 2017
Risks, benefits of canagliflozin | Advantages of team-based care | HbA1c in black patients | No advantage for self-monitoring in some patients with T2DM.
- Univadis Medical News
- 1 comment
CHD patients should be screened for psychological distress
The recommendation follows new findings that persistent psychological distress is linked with a higher mortality risk
- Univadis Medical News
- 1 comment
Eating fish may improve arthritis symptoms
Increasing servings of fish were linked with incrementally lower levels of disease activity.
- Univadis Medical News
- 1 comment
EMA recommends approval of new hepatitis C treatments
The two therapies are the first medicines for which accelerated assessment has been carried out within 120 days.
